Ainos, Inc. (NASDAQ:AIMD) Short Interest Up 107.8% in December

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totaling 23,172 shares, a growth of 107.8% from the November 30th total of 11,153 shares. Based on an average daily volume of 31,273 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.5% of the shares of the stock are sold short. Approximately 0.5% of the shares of the stock are sold short. Based on an average daily volume of 31,273 shares, the days-to-cover ratio is currently 0.7 days.

Ainos Stock Down 1.4%

Shares of NASDAQ:AIMD opened at $1.95 on Monday. The company has a market cap of $9.40 million, a price-to-earnings ratio of -0.49 and a beta of 2.39. Ainos has a 12 month low of $1.78 and a 12 month high of $5.00. The company has a current ratio of 2.96, a quick ratio of 2.67 and a debt-to-equity ratio of 1.10. The company has a 50-day moving average price of $2.57 and a 200 day moving average price of $3.01.

Ainos (NASDAQ:AIMD) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.64) earnings per share (EPS) for the quarter. The business had revenue of $0.00 million during the quarter.

Analysts Set New Price Targets

AIMD has been the subject of a number of research reports. Wall Street Zen raised Ainos from a “sell” rating to a “hold” rating in a research note on Friday, September 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ainos in a report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ainos has a consensus rating of “Sell”.

Insider Transactions at Ainos

In other Ainos news, major shareholder Carbon Nano Technology Taiwan sold 7,000 shares of the business’s stock in a transaction on Monday, October 6th. The shares were sold at an average price of $3.59, for a total value of $25,130.00. Following the sale, the insider owned 1,037,206 shares in the company, valued at $3,723,569.54. The trade was a 0.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 9.79% of the company’s stock.

Institutional Trading of Ainos

A hedge fund recently bought a new stake in Ainos stock. Two Sigma Investments LP acquired a new position in shares of Ainos, Inc. (NASDAQ:AIMD) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned 0.48% of Ainos as of its most recent SEC filing.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical?stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI?401, is an inhaled formulation of ibuprofen in a dry powder format.